Natural Killer Cells Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Natural Killer Cells Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : December, 2019 | Biotechnology | PPT format

Report Digest


Natural Killer Cells Therapeutics Market: Overview

Natural killer cells are generally big granular lymphocytes. These cells react quickly to any pathological problem. In addition to this, these natural killer cells are responsible for the production of immunoregulatory cytokines. Also, these natural killer cells act as a key component of the overall immune system of the humans. The role of these natural killer cells is the produce a quick immune response against different types of infections and malignancies.

Natural Killer Cells Therapeutics Market: Notable Developments

Some of the key developments in the global natural killer cells therapeutics market are given below:

  • In August 2019, Celgene Corporation announced that the company has been successful in getting the approval from the US Food and Drug Administration for the introduction of INREBI® (fedratinib). This new drug is curated to treat adults who are suffering from high-risk primary or secondary or intermediate-2 or myelofibrosis.
  • In August 2018, Affimed NV announced that the company has entered into a strategic agreement of collaborating with Genetech. Genetech is a prominent brand under Roche Group. The objective behind the agreement is to develop, commercialize, and market new natural killer engager-based immunotherapeutics for the treatment of different types of cancer.

Natural Killer Cells Therapeutics Market: Drivers and Restraints

There are numerous factors that are exerting a strong influence on the overall development of the global natural killer cells therapeutics market. One of the key driving factors for the growth of the market have been the increasing adoption of these natural killer cells for the treatment of various disease include liver diseases, infections, and cancer. In addition to this, these natural killer cells play a crucial role in the immune surveillance of tumor that pushes the adoption natural killer cells therapeutics across the world.

There are however, some factors that may derail the growth of the global natural killer cells therapeutics market. Adverse side effects, poor in-vivo therapies, and lack of certainty have been the key restraining factor for the growth of the natural killer cells therapeutics market.

Nonetheless, the growing awareness about the several immunotherapies has also been a crucial factor for the growth of the global natural killer cells therapeutics market. Moreover, the increased funding and investments for the research and development activities has played in developing newer therapeutics and expanding the reach of the market even further.

Natural Killer Cells Therapeutics Market: Geographical Outlook

In terms of geographical segmentation, the global natural killer cells therapeutics market has five key regions viz. North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of these, the natural killer cells therapeutics market is currently dominated by the North America region. The region is also expected to continue to lead the global market over the course of the given forecast period of 2018 to 2028. The growth of the North America natural killer cells therapeutics market is mainly attributed to the considerable growth of the in the prevalence of cancer in the region.

However, the region of Asia Pacific is expected to exhibit a higher CAGR over the course of the given forecast period. This high growth of the market in the region is down to the presence of emerging economies such as India and China. These developing nations are spending heavily on the development of their medical and healthcare infrastructure. This has led to increasing funding for research and development activities that has ultimately benefitted the growth of the natural killer cells therapeutics market.

Natural Killer Cells Therapeutics Market Segments:

By Therapeutics

  • NK Cell Therapies
  • NK Cell Directed Antibodies

By Application

  • Cancer 
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
  • Others

By End User

  • Research Centers & Institutes 
  • Hospitals
  • Others

The study presents reliable qualitative and quantitative insights into:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand chain of the market
  • Market valuation (revenue and/or volume)
  • Key trends/opportunities/challenges
  • Forces defining present and estimated future state of the competitive landscape
  • Technological developments
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.

Highlights of the report:

  • A detailed analysis of key segments of the market
  • Recent developments in the market’s competitive landscape
  • Detailed analysis of market segments up to second or third level of segmentation
  • Historical, current, and projected future valuation of the market in terms of revenue and/or volume
  • Key business strategies adopted by influential market vendors
  • Outline of the regulatory framework surrounding and governing numerous aspects of the market
  • Growth opportunities in emerging and established markets
  • Recommendations to market players to stay ahead of the competition

Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC